A report titled “Global Chronic Respiratory Diseases Treatment Market” іѕ rесеntlу рublіѕhеd bу Eternal markets. Тhе mаrkеt hаѕ bееn ѕеgmеntеd оn thе bаѕіѕ оf type, application, route of Administration, distribution channel, rеgіоnѕ аnd соuntrіеѕ. Rеvеnuе frоm thе glоbаl chronic respiratory diseases treatment mаrkеt іѕ рrојесtеd tо rеасh а vаluе оf UЅ$ 74,188.8 Мn іn 2029.
Industry Overview:
The chronic respiratory diseases have adverse effects on the respiratory organs. Chronic respiratory diseases includes occupational lung diseases, asthma, pulmonary fibrosis, chronic sinusitis, chronic obstructive pulmonary disease, lung cancer, sleep apnea, cystic fibrosis, occupational lung diseases and others. These diseases have no cure but can be treatable. Chronic obstructive pulmonary disease and asthma are two of the most common chronic respiratory diseases. Symptoms include such as chronic cough, breathlessness, wheezing and others. Treatment can prevent complications, ease symptoms, and generally slow disease evolution.
Market Dynamics:
Maximum developing countries where fast industrialization is in, are beholding an increase in the level of air pollution which is one of the main risk factors for chronic respiratory diseases such as asthma and COPD. According to the Global Asthma Report, 2018, more than 1 billion people are affected by pulmonary diseases. High level of pollution donates to the growing number of respiratory disease patients which can more lead to the growth of chronic respiratory diseases treatment market.
Augmented demand coupled with the need of developing a vaccine is expected to drive the chronic respiratory disease treatment market in the upcoming few years.
Some factors are accountable for restrain the growth such as limited adoption rate of surgical treatments in developing/underdeveloped economies due to inexperienced doctors, limited spending on healthcare infrastructure may hinder the market growth.
Rising manufacturer focus to create a more advanced treatment in the market will further create a new opportunity for the chronic respiratory diseases treatment market for the forecast period of 2023 to 2032. The trends such as, advances in medical imaging, product launches, geographic expansions, technological innovations in the market are the factors which are strongly involved to increase the growth of the market globally.
Rеgіоn-wіѕе ѕеgmеntаtіоn in the global chronic respiratory diseases treatment market іnсludеѕ North Аmеrіса, Еurоре, Аѕіа Расіfіс, Ѕоuth Аmеrіса, аnd the Міddlе Еаѕt & Аfrіса. North Аmеrіса ассоunted for hіghеѕt rеvеnuе ѕhаrе in the global chronic respiratory diseases treatment market currently.
Іn 2024, the North Аmеrіса market іѕ ехресtеd tо ассоunt fоr а rеvеnuе оf UЅ$ 20,728.5 Мn, аnd іѕ рrојесtеd tо rеgіѕtеr а CAGR of 4.5% оvеr thе fоrесаѕt реrіоd. China chronic respiratory diseases treatment mаrkеt was ассоuntеd fоr а rеvеnuе оf UЅ$ 4,527.7 Мn in 2020, аnd іѕ рrојесtеd tо rеgіѕtеr а САGR of about 11.8% оvеr thе 10-уеаr fоrесаѕt реrіоd.
Industry Developments:
Year 2020: Acquisition; AstraZeneca has entered into an agreement with Dogma Therapeutics to acquire its preclinical oral PCSK9 inhibitor programme.
Year 2020: Agreement; Vectura announces that it has signed an agreement with Monash University’s Institute of Pharmaceutical Sciences (MIPS), to develop inhaled oxytocin delivered via a dry powder inhaler to prevent postpartum hemorrhage (PPH) in childbirth.
Year 2020: Agreement; Mylan N.V. (NASDAQ: MYL) announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited’s thrombosis business in Europe.
Year 2019: The scientific research for new therapeutic concepts to help patients with respiratory diseases continues to be of high importance for Boehringer Ingelheim.
Major Strategies adopted by key market players:
- Agreements, Collaborations, and Partnerships: 30%
- Acquisitions: 14%
- New Service Launch: _%
- Other Developments: _%
Scope of the Report:
Global Chronic Respiratory Diseases Treatment Market, by Type
- Chronic Disease Obstructive
- Asthma
- Others
Global Chronic Respiratory Diseases Treatment Market, by Application
- Combination Product
- Leukotriene Antagonists (LTA)
- Inhaled Corticosteroids (ICS)
- Bronchodilators
- Antibiotics
- Others
Global Chronic Respiratory Diseases Treatment Market, by Route of Administration
- Inhalational
- Oral
- Parenteral
Global Chronic Respiratory Diseases Treatment Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Chronic Respiratory Diseases Treatment Market, by Geography
-
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe (RoE)
-
- China
- Japan
- India
- Rest of APAC (RoAPAC)
-
- Brazil
- Argentina
- Rest of South America
-
- GCC
- Israel
- South Africa
- Rest of MEA
Competitors landscape:
- Mylan N.V.
- Sumitomo Dainippon Pharma Co. Ltd.
- Boehringer Ingelheim Pharmaceuticals Inc.
- GlaxoSmithKline plc.
- Teva Pharmaceuticals Inc
- AstraZeneca Plc.
- Merck & Co., Inc
- Novartis AG
- CHIESI Farmaceutici SpA
- Sunovion Pharmaceuticals Inc
- Orion Corporation
- Grifols, S.A.
- Abbott
- Hoffmann-La Roche Ltd
- Vectura Group plc
- Pfizer Inc
- Alkermes
- Almirall, S.A
- Genentech, Inc
- Biogen
- Astellas Pharma Inc
- Other Companies
*The report scope shall be customized as per the requirements
Chapter 1 Global Chronic Respiratory Diseases Treatment Market Overview
1.1 Introduction
1.2 Drivers for Chronic Respiratory Diseases Treatment Market
1.3 Restraints for Chronic Respiratory Diseases Treatment Market
1.4 Opportunities for Chronic Respiratory Diseases Treatment Market
1.5 Trends for Chronic Respiratory Diseases Treatment Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Chronic Respiratory Diseases Treatment Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Mylan N.V.
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Sumitomo Dainippon Pharma Co. Ltd.
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Boehringer Ingelheim Pharmaceuticals Inc.
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 GlaxoSmithKline plc.
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Teva Pharmaceuticals Inc.
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 AstraZeneca Plc.
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 Merck & Co., Inc.
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Novartis AG
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 CHIESI Farmaceutici SpA
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Sunovion Pharmaceuticals Inc.
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Chronic Respiratory Diseases Treatment Market Overview
3.1 Global Chronic Respiratory Diseases Treatment Market Outlook (2017-2032)
3.1.1 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2017-2023)
3.1.2 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2024-2032)
3.2 Global Chronic Respiratory Diseases Treatment Market by Region
3.2.1 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2032)
3.2.2 Global Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Chronic Respiratory Diseases Treatment Market by Type
3.3.1 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2032)
3.3.2 Global Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Type, 2023–2032
3.3.3 Global Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Chronic Respiratory Diseases Treatment Market by Application
3.4.1 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2032)
3.4.2 Global Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Application, 2023–2032
3.5 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Region
3.5.1 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2023)
3.5.2 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2024-2032)
3.6 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Type
3.6.1 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2023)
3.6.2 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2024-2032)
3.7 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Application
3.7.1 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2023)
3.7.2 Global Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2024-2032)
3.8 Global Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Region
3.8.2 Global Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Type
3.8.3 Global Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Application
3.9 Global Chronic Respiratory Diseases Treatment Market Share Comparison 2017–2032
3.9.1 Global Chronic Respiratory Diseases Treatment Market Share by Region
3.9.2 Global Chronic Respiratory Diseases Treatment Market Share by Type
3.9.3 Global Chronic Respiratory Diseases Treatment Market Share by Application
Chapter 4 North America Chronic Respiratory Diseases Treatment Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Chronic Respiratory Diseases Treatment Market Outlook (2017-2032)
4.2.1 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2017-2023)
4.2.2 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2024-2032)
4.3 North America Chronic Respiratory Diseases Treatment Market by Region
4.3.1 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2032)
4.3.2 North America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Chronic Respiratory Diseases Treatment Market by Type
4.4.1 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2032)
4.4.2 North America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Type, 2023–2032
4.4.3 North America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Chronic Respiratory Diseases Treatment Market by Application
4.5.1 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2032)
4.5.2 North America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Application, 2023–2032
4.6 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Region
4.6.1 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2023)
4.6.2 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2024-2032)
4.7 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Type
4.7.1 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2023)
4.7.2 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2024-2032)
4.8 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Application
4.8.1 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2023)
4.8.2 North America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2024-2032)
4.9 North America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Region
4.9.2 North America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Type
4.9.3 North America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Application
4.1 North America Chronic Respiratory Diseases Treatment Market Share Comparison 2017–2032
4.10.1 North America Chronic Respiratory Diseases Treatment Market Share by Region
4.10.2 North America Chronic Respiratory Diseases Treatment Market Share by Type
4.10.3 North America Chronic Respiratory Diseases Treatment Market Share by Application
Chapter 5 Europe Chronic Respiratory Diseases Treatment Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Chronic Respiratory Diseases Treatment Market Outlook (2017-2032)
5.2.1 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2017-2023)
5.2.2 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2024-2032)
5.3 Europe Chronic Respiratory Diseases Treatment Market by Region
5.3.1 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2032)
5.3.2 Europe Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Chronic Respiratory Diseases Treatment Market by Type
5.4.1 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2032)
5.4.2 Europe Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Type, 2023–2032
5.4.3 Europe Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Chronic Respiratory Diseases Treatment Market by Application
5.5.1 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2032)
5.5.2 Europe Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Application, 2023–2032
5.6 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Region
5.6.1 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2023)
5.6.2 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2024-2032)
5.7 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Type
5.7.1 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2023)
5.7.2 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2024-2032)
5.8 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Application
5.8.1 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2023)
5.8.2 Europe Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2024-2032)
5.9 Europe Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Region
5.9.2 Europe Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Type
5.9.3 Europe Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Application
5.1 Europe Chronic Respiratory Diseases Treatment Market Share Comparison 2017–2032
5.10.1 Europe Chronic Respiratory Diseases Treatment Market Share by Region
5.10.2 Europe Chronic Respiratory Diseases Treatment Market Share by Type
5.10.3 Europe Chronic Respiratory Diseases Treatment Market Share by Application
Chapter 6 Asia Pacific Chronic Respiratory Diseases Treatment Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Outlook (2017-2032)
6.2.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2017-2023)
6.2.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2024-2032)
6.3 Asia Pacific Chronic Respiratory Diseases Treatment Market by Region
6.3.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Chronic Respiratory Diseases Treatment Market by Type
6.4.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2032)
6.4.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Type, 2023–2032
6.4.3 Asia Pacific Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Chronic Respiratory Diseases Treatment Market by Application
6.5.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2032)
6.5.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Application, 2023–2032
6.6 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Region
6.6.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2024-2032)
6.7 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Type
6.7.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2023)
6.7.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2024-2032)
6.8 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Application
6.8.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2023)
6.8.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2024-2032)
6.9 Asia Pacific Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Type
6.9.3 Asia Pacific Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Application
6.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Share Comparison 2017–2032
6.10.1 Asia Pacific Chronic Respiratory Diseases Treatment Market Share by Region
6.10.2 Asia Pacific Chronic Respiratory Diseases Treatment Market Share by Type
6.10.3 Asia Pacific Chronic Respiratory Diseases Treatment Market Share by Application
Chapter 7 South America Chronic Respiratory Diseases Treatment Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Chronic Respiratory Diseases Treatment Market Outlook (2017-2032)
7.2.1 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2017-2023)
7.2.2 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2024-2032)
7.3 South America Chronic Respiratory Diseases Treatment Market by Region
7.3.1 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2032)
7.3.2 South America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Chronic Respiratory Diseases Treatment Market by Type
7.4.1 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2032)
7.4.2 South America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Type, 2023–2032
7.4.3 South America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Chronic Respiratory Diseases Treatment Market by Application
7.5.1 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2032)
7.5.2 South America Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Application, 2023–2032
7.6 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Region
7.6.1 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2023)
7.6.2 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2024-2032)
7.7 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Type
7.7.1 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2023)
7.7.2 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2024-2032)
7.8 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Application
7.8.1 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2023)
7.8.2 South America Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2024-2032)
7.9 South America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Region
7.9.2 South America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Type
7.9.3 South America Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Application
7.1 South America Chronic Respiratory Diseases Treatment Market Share Comparison 2017–2032
7.10.1 South America Chronic Respiratory Diseases Treatment Market Share by Region
7.10.2 South America Chronic Respiratory Diseases Treatment Market Share by Type
7.10.3 South America Chronic Respiratory Diseases Treatment Market Share by Application
Chapter 8 Middle East and Africa Chronic Respiratory Diseases Treatment Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Outlook (2017-2032)
8.2.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2017-2023)
8.2.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) (2024-2032)
8.3 Middle East and Africa Chronic Respiratory Diseases Treatment Market by Region
8.3.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Chronic Respiratory Diseases Treatment Market by Type
8.4.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2032)
8.4.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Type, 2023–2032
8.4.3 Middle East and Africa Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Chronic Respiratory Diseases Treatment Market by Application
8.5.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2032)
8.5.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Attractiveness Analysis by Application, 2023–2032
8.6 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Region
8.6.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Region (2024-2032)
8.7 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Type
8.7.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2017-2023)
8.7.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Type (2024-2032)
8.8 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) by Application
8.8.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2017-2023)
8.8.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Value (US$ Mn) Comparison by Application (2024-2032)
8.9 Middle East and Africa Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Type
8.9.3 Middle East and Africa Chronic Respiratory Diseases Treatment Market Y-o-Y Growth Rate by Application
8.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Chronic Respiratory Diseases Treatment Market Share by Region
8.10.2 Middle East and Africa Chronic Respiratory Diseases Treatment Market Share by Type
8.10.3 Middle East and Africa Chronic Respiratory Diseases Treatment Market Share by Application
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
